Pulmonx Corporation (LUNG)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Pulmonx Corporation (LUNG) is down 42.5% since the beginning of the year. At $1 per share, LUNG is trading 67.3% below its 52-week high of $4. Investors who bought $1,000 worth of LUNG shares 5 years ago would now be looking at an investment worth $29.

Pulmonx Corporation (LUNG) has returned -42.53% so far this year and -51.53% over the past 12 months.

Based on dividend-adjusted daily data since Oct 1, 2020, LUNG's average daily return is -0.11%, while the average monthly return is -2.94%.

Historically, 45% of months were positive and 55% were negative. The best month was Feb 2025 with a return of +51.8%, while the worst month was Nov 2022 at -54.9%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.

On a daily basis, LUNG closed higher 47% of trading days. The best single day was Feb 20, 2025 with a return of +32.2%, while the worst single day was Nov 4, 2022 at -60.9%.

Pulmonx Corporation has an annualized alpha of -38.86%, beta of 1.41, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since October 01, 2020.

• This stock participated in 149.95% of S&P 500 Index downside but only -66.84% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

LUNG ranks 20 for risk / return — below 20% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Pulmonx Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Pulmonx Corporation was 98.30%, occurring on Mar 27, 2026. The portfolio has not yet recovered.

The current Pulmonx Corporation drawdown is 98.16%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Pulmonx Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Pulmonx Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.